APP and Alzheimer disease: Furthermore, unlike many prior studies that utilize APP overexpressing transgenic mice, we use the APPNL‐G‐F knock‐in mouse model, which more faithfully replicates the gradual progression of Aβ pathology seen in human AD, without overexpression of APP.5